Local control with multimodality therapy for Stage 4 neuroblastoma Academic Article Article uri icon

Overview

MeSH Major

  • Antibodies, Bispecific
  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Carcinoma, Hepatocellular
  • Immunotherapy
  • Liver Neoplasms
  • Receptors, Antigen
  • Recombinant Fusion Proteins

abstract

  • Hyperfractionated radiotherapy to 21 Gy, in conjunction with dose-intensive systemic therapy and aggressive surgical resection, is well tolerated and is associated with durable local control for most patients with Stage 4 neuroblastoma.

publication date

  • March 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0360-3016(99)00399-5

PubMed ID

  • 10705019

Additional Document Info

start page

  • 969

end page

  • 74

volume

  • 46

number

  • 4